A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD)

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

January 19, 2024

Study Completion Date

August 19, 2024

Conditions
PolypharmacyDementia
Interventions
BEHAVIORAL

Educational nudge intervention

This project will adapt the EMPOWER educational brochure for PLWD receiving CNS polyRx. The educational brochure will be mailed to intervention participants identified through EHR at Michigan Medicine and Henry Ford Health System. The brochure will describe what CNS polyRx is, present information about the associated risks, and suggest that participants speak with the prescribing clinician or pharmacist about ways to potentially simplify the medication regimen. The tool will be adapted through three successive rounds of focus groups (AIM one of this project) of PLWD.

Trial Locations (2)

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health, Detroit

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Michigan

OTHER

NCT05628181 - A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD) | Biotech Hunter | Biotech Hunter